Isao Uno
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Isao Uno has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Hiroaki Takahashi
Mayo Clinic, Rochester, USA
1 shared publication Hirofumi Ogihara
Department of Rehabilitation, Faculty of Health Sciences Nagano University of Health and Medicine Nagano Japan
1 shared publication- Isao H. Inoue
National Institute of Advanced Industrial Science and Technology (AIST)
1 shared publication Itoji Shibata
Osaka Medical College)
1 shared publicationKazuo Makimoto
Hirakata Municipal Hospital)
1 shared publicationKohei Wada
Tottori Prefectural Central Hospital)
1 shared publication
Latest Publications
- 25 August 2026
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 26 (9)
Impact of Frailty on Activities of Daily Living in Hospitalized Older Adults: A Systematic Review and Meta‐Analysis
Aim: To determine whether frailty is associated with activities of daily living (ADL) and other clinical outcomes in hospitalized older adults. Methods: MEDLINE, Embase and CENTRAL were searched for English‐language cohort studies published from 1 January 2001 to 23 October 2025. Eligible studies included hospitalized adults aged ≥ 65 years (or samples with ≥ 80% aged ≥ 65 years), used a defined frailty measure and compared frail with non‐frail participants. Two reviewers independently selected studies, extracted data and assessed risk of bias using the Quality In Prognosis Studies tool. Random‐effects meta‐analyses generated standardized mean differences (SMDs) or risk ratios (RRs) with 95% confidence intervals (CIs). Results: Fifty‐seven cohort studies were included. Frailty was associated with worse ADL status (SMD −1.04, 95% CI −1.89 to −0.20), higher mortality (RR 2.26, 95% CI 1.86–2.76), lower likelihood of discharge home (RR 0.79, 95% CI 0.73–0.86), and higher 30‐day (RR 1.47, 95% CI 1.13–1.90) and 90‐day readmission risks (RR 1.75, 95% CI 1.07–2.86). Pneumonia risk was not statistically significant. Heterogeneity was substantial to considerable for all pooled outcomes. Conclusions: Frailty identifies hospitalized older adults at increased risk of functional dependence, mortality, non‐home discharge, and readmission. Substantial heterogeneity and residual confounding warrant cautious interpretation and support standardized frailty and functional‐outcome assessment.
- 25 August 2026
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 26 (9)
Impact of Frailty on Activities of Daily Living in Hospitalized Older Adults: A Systematic Review and Meta‐Analysis
Aim: To determine whether frailty is associated with activities of daily living (ADL) and other clinical outcomes in hospitalized older adults. Methods: MEDLINE, Embase and CENTRAL were searched for English‐language cohort studies published from 1 January 2001 to 23 October 2025. Eligible studies included hospitalized adults aged ≥ 65 years (or samples with ≥ 80% aged ≥ 65 years), used a defined frailty measure and compared frail with non‐frail participants. Two reviewers independently selected studies, extracted data and assessed risk of bias using the Quality In Prognosis Studies tool. Random‐effects meta‐analyses generated standardized mean differences (SMDs) or risk ratios (RRs) with 95% confidence intervals (CIs). Results: Fifty‐seven cohort studies were included. Frailty was associated with worse ADL status (SMD −1.04, 95% CI −1.89 to −0.20), higher mortality (RR 2.26, 95% CI 1.86–2.76), lower likelihood of discharge home (RR 0.79, 95% CI 0.73–0.86), and higher 30‐day (RR 1.47, 95% CI 1.13–1.90) and 90‐day readmission risks (RR 1.75, 95% CI 1.07–2.86). Pneumonia risk was not statistically significant. Heterogeneity was substantial to considerable for all pooled outcomes. Conclusions: Frailty identifies hospitalized older adults at increased risk of functional dependence, mortality, non‐home discharge, and readmission. Substantial heterogeneity and residual confounding warrant cautious interpretation and support standardized frailty and functional‐outcome assessment.
- Open Access
- 8 April 2026
- Published by Springer Nature in Cureus
- Vol. 18 (4)
Prediction of Discharge Functional Independence Measure Scores From Routine Admission Variables Using a ChatGPT-Assisted Workflow in Patients With Cerebral Infarction or Intracerebral Hemorrhage: A Retrospective Observational Study
- 8 April 2026
- Published by Springer Nature in Cureus
- Vol. 18 (4)
Open AccessPrediction of Discharge Functional Independence Measure Scores From Routine Admission Variables Using a ChatGPT-Assisted Workflow in Patients With Cerebral Infarction or Intracerebral Hemorrhage: A Retrospective Observational Study
- Open Access
- 20 March 2025
- Published by Springer Nature in Cureus
- Vol. 17 (3) , e80864
Rehabilitation of a Patient With Bickerstaff Brainstem Encephalitis Presenting With Ataxia
Bickerstaff brainstem encephalitis (BBE) is a rare autoimmune disorder characterized by oculomotor disturbances, ataxia, and impaired consciousness, likely caused by brainstem inflammation. Although acute immunotherapy, including corticosteroids, plasma exchange, and intravenous immunoglobulin, appears to effectively mitigate the inflammatory process, residual neurological deficits often persist, necessitating individualized rehabilitation strategies. We report the case of a 40-year-old male with BBE who presented with severe impaired consciousness, ataxia, and diplopia following flu-like symptoms. Despite initial immunotherapeutic interventions, the patient continued to experience significant functional limitations, as evidenced by a Functional Independence Measure (FIM) score of 78, a Berg Balance Scale (BBS) score of 22, and a Scale for the Assessment and Rating of Ataxia (SARA) score of 20 upon admission to the rehabilitation ward. An intensive, stepwise, and individualized rehabilitation program was implemented. The protocol initially emphasized static and dynamic balance exercises on stable surfaces, trunk and limb strengthening, and environmental modifications to address diplopia. From the second week, task-specific gait training, including applied stepping, stair climbing, and oculomotor exercises, was introduced. After the third week, the regimen progressed to outdoor ambulation and activities simulating real-life tasks to facilitate social reintegration and occupational readiness. Following 41 days of rehabilitation, marked improvements were observed. The patient's FIM score increased from 78 to 121, BBS improved from 22 to 56, and SARA score decreased from 20 to 3, indicating significant amelioration of ataxia. Enhanced performance on the Timed Up and Go (TUG) test and the 10-meter walk test, as well as an increased 6-minute walking distance, reflected improved balance, mobility, and endurance. Additionally, the patient's diplopia improved, enabling safe ambulation and the successful resumption of leisure activities. This case underscores the pivotal role of an individualized, timely rehabilitation program in facilitating functional recovery in patients with BBE. Task-specific training and sensorimotor integration strategies appear to promote neural plasticity and improve motor and oculomotor functions. Further research is warranted to develop and validate evidence-based rehabilitation protocols tailored to BBE and similar autoimmune neurological disorders.
- 20 March 2025
- Published by Springer Nature in Cureus
- Vol. 17 (3) , e80864
Open AccessRehabilitation of a Patient With Bickerstaff Brainstem Encephalitis Presenting With Ataxia
Bickerstaff brainstem encephalitis (BBE) is a rare autoimmune disorder characterized by oculomotor disturbances, ataxia, and impaired consciousness, likely caused by brainstem inflammation. Although acute immunotherapy, including corticosteroids, plasma exchange, and intravenous immunoglobulin, appears to effectively mitigate the inflammatory process, residual neurological deficits often persist, necessitating individualized rehabilitation strategies. We report the case of a 40-year-old male with BBE who presented with severe impaired consciousness, ataxia, and diplopia following flu-like symptoms. Despite initial immunotherapeutic interventions, the patient continued to experience significant functional limitations, as evidenced by a Functional Independence Measure (FIM) score of 78, a Berg Balance Scale (BBS) score of 22, and a Scale for the Assessment and Rating of Ataxia (SARA) score of 20 upon admission to the rehabilitation ward. An intensive, stepwise, and individualized rehabilitation program was implemented. The protocol initially emphasized static and dynamic balance exercises on stable surfaces, trunk and limb strengthening, and environmental modifications to address diplopia. From the second week, task-specific gait training, including applied stepping, stair climbing, and oculomotor exercises, was introduced. After the third week, the regimen progressed to outdoor ambulation and activities simulating real-life tasks to facilitate social reintegration and occupational readiness. Following 41 days of rehabilitation, marked improvements were observed. The patient's FIM score increased from 78 to 121, BBS improved from 22 to 56, and SARA score decreased from 20 to 3, indicating significant amelioration of ataxia. Enhanced performance on the Timed Up and Go (TUG) test and the 10-meter walk test, as well as an increased 6-minute walking distance, reflected improved balance, mobility, and endurance. Additionally, the patient's diplopia improved, enabling safe ambulation and the successful resumption of leisure activities. This case underscores the pivotal role of an individualized, timely rehabilitation program in facilitating functional recovery in patients with BBE. Task-specific training and sensorimotor integration strategies appear to promote neural plasticity and improve motor and oculomotor functions. Further research is warranted to develop and validate evidence-based rehabilitation protocols tailored to BBE and similar autoimmune neurological disorders.
- Open Access
- 30 November 2021
- Published by MDPI AG in Geriatrics
- Vol. 6 (4) , 113
Risk Factors for Aspiration Pneumonia among Elderly Patients in a Community-Based Integrated Care Unit: A Retrospective Cohort Study
We aimed to clarify the physical factors associated with the incidence of aspiration pneumonia in a community-based integrated care unit. This retrospective cohort study included 412 patients aged 65 years or older admitted to a community-based integrated care unit. A new diagnosis of aspiration pneumonia made by the attending physician based on physical examination, imaging findings, and blood test data after 48 h of admission was considered as an incidence of aspiration pneumonia. Basic patient information, activities of daily living, swallowing function, nutritional status, cognitive function, oral health-related factors, and energy intake were retrospectively investigated. We classified the patients into a pneumonia group and a non-pneumonia group, and examined the factors associated with the development of aspiration pneumonia. The mean age was 86.9 ± 8.1 years, and the pneumonia group comprised 49 participants. Comparison between the groups showed significant differences in oral environment, denture use, cognitive functional independence measure, and discharge to home. In multivariate logistic regression analysis, oral environment (odds ratio (OR) = 0.229, 95% confidence interval (CI): 0.070–0.753, p = 0.015) and use of dentures (OR = 0.360, 95% CI: 0.172–0.754, p = 0.007) were independently associated with aspiration pneumonia. Oral care and the use of dentures may be effective in preventing aspiration pneumonia.
- 30 November 2021
- Published by MDPI AG in Geriatrics
- Vol. 6 (4) , 113
Open AccessRisk Factors for Aspiration Pneumonia among Elderly Patients in a Community-Based Integrated Care Unit: A Retrospective Cohort Study
We aimed to clarify the physical factors associated with the incidence of aspiration pneumonia in a community-based integrated care unit. This retrospective cohort study included 412 patients aged 65 years or older admitted to a community-based integrated care unit. A new diagnosis of aspiration pneumonia made by the attending physician based on physical examination, imaging findings, and blood test data after 48 h of admission was considered as an incidence of aspiration pneumonia. Basic patient information, activities of daily living, swallowing function, nutritional status, cognitive function, oral health-related factors, and energy intake were retrospectively investigated. We classified the patients into a pneumonia group and a non-pneumonia group, and examined the factors associated with the development of aspiration pneumonia. The mean age was 86.9 ± 8.1 years, and the pneumonia group comprised 49 participants. Comparison between the groups showed significant differences in oral environment, denture use, cognitive functional independence measure, and discharge to home. In multivariate logistic regression analysis, oral environment (odds ratio (OR) = 0.229, 95% confidence interval (CI): 0.070–0.753, p = 0.015) and use of dentures (OR = 0.360, 95% CI: 0.172–0.754, p = 0.007) were independently associated with aspiration pneumonia. Oral care and the use of dentures may be effective in preventing aspiration pneumonia.
- Open Access
- 1 January 1993
- Published by The Society of Practical Otolaryngology in Practica Oto-Rhino-Laryngologica
- Vol. 86 (10) , 1499-1508
Studies on the Clinical Feasibility of Keigai-Rengyo-To for Chronic Sinusitis.
A clinical study was conducted on the feasibility of herbal medicine TJ-50 (Tsumura Keigai-rengyo-to) in treating chronic sinusitis. Thirty-nine patients were enrolled in this study (male 16, female 23), ranging from 16 to 86 years old. In all patients, Keigai-rengyo-to was administered orally three times daily for four to eight weeks. A higher rate of improvement in subjective symptoms were observed for postnasal drip, rhinorrhea and nasal obstruction, as well as for postnasal drip and volume of nasal mucus on rhinoscopic findings. When evaluation was based on both subjective symptoms and objective findings, 28 of 38 (73.7%) cases were graded as “slightly effective” or higher. This improvement rate was higher in the patient group with less than 12 months duration of chronic sinusitis. On X-ray findings of the paranasal sinuses, seven of 23 (30.4%) cases were graded “slightly effective”. No patient attained the grade “effective” or “markedly effective”. As to the clinical feasibility of Keigai-rengyo-to, judged from the above evaluations and safety due to fewer potential side effects, the grad “useful” was obtained in ten of 39 cases (25.6%) and more than “slightly useful” in 22 of 39 cases (56.4%). Side effects were observed in one case of eruptions which disappeared after treatment was discontinued, and in two cases of gastric symptoms. Gastric symptoms were mild, and were alleviated as the treatment was continued.
- 1 January 1993
- Published by The Society of Practical Otolaryngology in Practica Oto-Rhino-Laryngologica
- Vol. 86 (10) , 1499-1508
Open AccessStudies on the Clinical Feasibility of Keigai-Rengyo-To for Chronic Sinusitis.
A clinical study was conducted on the feasibility of herbal medicine TJ-50 (Tsumura Keigai-rengyo-to) in treating chronic sinusitis. Thirty-nine patients were enrolled in this study (male 16, female 23), ranging from 16 to 86 years old. In all patients, Keigai-rengyo-to was administered orally three times daily for four to eight weeks. A higher rate of improvement in subjective symptoms were observed for postnasal drip, rhinorrhea and nasal obstruction, as well as for postnasal drip and volume of nasal mucus on rhinoscopic findings. When evaluation was based on both subjective symptoms and objective findings, 28 of 38 (73.7%) cases were graded as “slightly effective” or higher. This improvement rate was higher in the patient group with less than 12 months duration of chronic sinusitis. On X-ray findings of the paranasal sinuses, seven of 23 (30.4%) cases were graded “slightly effective”. No patient attained the grade “effective” or “markedly effective”. As to the clinical feasibility of Keigai-rengyo-to, judged from the above evaluations and safety due to fewer potential side effects, the grad “useful” was obtained in ten of 39 cases (25.6%) and more than “slightly useful” in 22 of 39 cases (56.4%). Side effects were observed in one case of eruptions which disappeared after treatment was discontinued, and in two cases of gastric symptoms. Gastric symptoms were mild, and were alleviated as the treatment was continued.